Experts call for caution when using antenatal corticosteroids

Two new studies published by The BMJ today examine the potential health risks for infants of giving steroid drugs to women who are at risk of giving birth early.

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 01.10.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

October 2, 2024

UCB adds three more FDA approvals to label for potential blockbuster Bimzelx

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 24, 2024

As Washington mulls new AI rules, startup leaders want a seat at the table

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.